Table of Contents Chapter 1 Overview of Diagnostic Biomarkers 1.1 Definition of Diagnostic Biomarkers in This Report 1.2 Commercial Types of Diagnostic Biomarkers 1.2.1 Safety Biomarkers 1.2.2 Efficacy Biomarkers 1.2.3 Validation Biomarkers 1.3 Downstream Application of Diagnostic Biomarkers 1.3.1 Hospitals 1.3.2 Cancer Research Institutes 1.3.3 Diagnostic Labs 1.4 Development History of Diagnostic Biomarkers 1.5 Market Status and Trend of Diagnostic Biomarkers 2013-2023 1.5.1 Global Diagnostic Biomarkers Market Status and Trend 2013-2023 1.5.2 Regional Diagnostic Biomarkers Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Diagnostic Biomarkers 2013-2017 2.2 Sales Market of Diagnostic Biomarkers by Regions 2.2.1 Sales Volume of Diagnostic Biomarkers by Regions 2.2.2 Sales Value of Diagnostic Biomarkers by Regions 2.3 Production Market of Diagnostic Biomarkers by Regions 2.4 Global Market Forecast of Diagnostic Biomarkers 2018-2023 2.4.1 Global Market Forecast of Diagnostic Biomarkers 2018-2023 2.4.2 Market Forecast of Diagnostic Biomarkers by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Diagnostic Biomarkers by Types 3.2 Sales Value of Diagnostic Biomarkers by Types 3.3 Market Forecast of Diagnostic Biomarkers by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Diagnostic Biomarkers by Downstream Industry 4.2 Global Market Forecast of Diagnostic Biomarkers by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Diagnostic Biomarkers Market Status by Countries 5.1.1 North America Diagnostic Biomarkers Sales by Countries (2013-2017) 5.1.2 North America Diagnostic Biomarkers Revenue by Countries (2013-2017) 5.1.3 United States Diagnostic Biomarkers Market Status (2013-2017) 5.1.4 Canada Diagnostic Biomarkers Market Status (2013-2017) 5.1.5 Mexico Diagnostic Biomarkers Market Status (2013-2017) 5.2 North America Diagnostic Biomarkers Market Status by Manufacturers 5.3 North America Diagnostic Biomarkers Market Status by Type (2013-2017) 5.3.1 North America Diagnostic Biomarkers Sales by Type (2013-2017) 5.3.2 North America Diagnostic Biomarkers Revenue by Type (2013-2017) 5.4 North America Diagnostic Biomarkers Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Diagnostic Biomarkers Market Status by Countries 6.1.1 Europe Diagnostic Biomarkers Sales by Countries (2013-2017) 6.1.2 Europe Diagnostic Biomarkers Revenue by Countries (2013-2017) 6.1.3 Germany Diagnostic Biomarkers Market Status (2013-2017) 6.1.4 UK Diagnostic Biomarkers Market Status (2013-2017) 6.1.5 France Diagnostic Biomarkers Market Status (2013-2017) 6.1.6 Italy Diagnostic Biomarkers Market Status (2013-2017) 6.1.7 Russia Diagnostic Biomarkers Market Status (2013-2017) 6.1.8 Spain Diagnostic Biomarkers Market Status (2013-2017) 6.1.9 Benelux Diagnostic Biomarkers Market Status (2013-2017) 6.2 Europe Diagnostic Biomarkers Market Status by Manufacturers 6.3 Europe Diagnostic Biomarkers Market Status by Type (2013-2017) 6.3.1 Europe Diagnostic Biomarkers Sales by Type (2013-2017) 6.3.2 Europe Diagnostic Biomarkers Revenue by Type (2013-2017) 6.4 Europe Diagnostic Biomarkers Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Diagnostic Biomarkers Market Status by Countries 7.1.1 Asia Pacific Diagnostic Biomarkers Sales by Countries (2013-2017) 7.1.2 Asia Pacific Diagnostic Biomarkers Revenue by Countries (2013-2017) 7.1.3 China Diagnostic Biomarkers Market Status (2013-2017) 7.1.4 Japan Diagnostic Biomarkers Market Status (2013-2017) 7.1.5 India Diagnostic Biomarkers Market Status (2013-2017) 7.1.6 Southeast Asia Diagnostic Biomarkers Market Status (2013-2017) 7.1.7 Australia Diagnostic Biomarkers Market Status (2013-2017) 7.2 Asia Pacific Diagnostic Biomarkers Market Status by Manufacturers 7.3 Asia Pacific Diagnostic Biomarkers Market Status by Type (2013-2017) 7.3.1 Asia Pacific Diagnostic Biomarkers Sales by Type (2013-2017) 7.3.2 Asia Pacific Diagnostic Biomarkers Revenue by Type (2013-2017) 7.4 Asia Pacific Diagnostic Biomarkers Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Diagnostic Biomarkers Market Status by Countries 8.1.1 Latin America Diagnostic Biomarkers Sales by Countries (2013-2017) 8.1.2 Latin America Diagnostic Biomarkers Revenue by Countries (2013-2017) 8.1.3 Brazil Diagnostic Biomarkers Market Status (2013-2017) 8.1.4 Argentina Diagnostic Biomarkers Market Status (2013-2017) 8.1.5 Colombia Diagnostic Biomarkers Market Status (2013-2017) 8.2 Latin America Diagnostic Biomarkers Market Status by Manufacturers 8.3 Latin America Diagnostic Biomarkers Market Status by Type (2013-2017) 8.3.1 Latin America Diagnostic Biomarkers Sales by Type (2013-2017) 8.3.2 Latin America Diagnostic Biomarkers Revenue by Type (2013-2017) 8.4 Latin America Diagnostic Biomarkers Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Diagnostic Biomarkers Market Status by Countries 9.1.1 Middle East and Africa Diagnostic Biomarkers Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Diagnostic Biomarkers Revenue by Countries (2013-2017) 9.1.3 Middle East Diagnostic Biomarkers Market Status (2013-2017) 9.1.4 Africa Diagnostic Biomarkers Market Status (2013-2017) 9.2 Middle East and Africa Diagnostic Biomarkers Market Status by Manufacturers 9.3 Middle East and Africa Diagnostic Biomarkers Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Diagnostic Biomarkers Sales by Type (2013-2017) 9.3.2 Middle East and Africa Diagnostic Biomarkers Revenue by Type (2013-2017) 9.4 Middle East and Africa Diagnostic Biomarkers Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Diagnostic Biomarkers 10.1 Global Economy Situation and Trend Overview 10.2 Diagnostic Biomarkers Downstream Industry Situation and Trend Overview Chapter 11 Diagnostic Biomarkers Market Competition Status by Major Manufacturers 11.1 Production Volume of Diagnostic Biomarkers by Major Manufacturers 11.2 Production Value of Diagnostic Biomarkers by Major Manufacturers 11.3 Basic Information of Diagnostic Biomarkers by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Diagnostic Biomarkers Major Manufacturer 11.3.2 Employees and Revenue Level of Diagnostic Biomarkers Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Diagnostic Biomarkers Major Manufacturers Introduction and Market Data 12.1 Qiagen N.V. 12.1.1 Company profile 12.1.2 Representative Diagnostic Biomarkers Product 12.1.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Qiagen N.V. 12.2 Perkinelmer, Inc. 12.2.1 Company profile 12.2.2 Representative Diagnostic Biomarkers Product 12.2.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Perkinelmer, Inc. 12.3 Merck Millipore 12.3.1 Company profile 12.3.2 Representative Diagnostic Biomarkers Product 12.3.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Merck Millipore 12.4 Bio-Rad Laboratories, Inc. 12.4.1 Company profile 12.4.2 Representative Diagnostic Biomarkers Product 12.4.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc. 12.5 Enzo Biochem, Inc. 12.5.1 Company profile 12.5.2 Representative Diagnostic Biomarkers Product 12.5.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Enzo Biochem, Inc. 12.6 EKF Diagnostics Holdings, Inc. 12.6.1 Company profile 12.6.2 Representative Diagnostic Biomarkers Product 12.6.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of EKF Diagnostics Holdings, Inc. 12.7 Meso Scale Diagnostics, LLC. 12.7.1 Company profile 12.7.2 Representative Diagnostic Biomarkers Product 12.7.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Meso Scale Diagnostics, LLC. 12.8 Biosims Technologies Sas 12.8.1 Company profile 12.8.2 Representative Diagnostic Biomarkers Product 12.8.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Biosims Technologies Sas 12.9 Cisbio Bioassays 12.9.1 Company profile 12.9.2 Representative Diagnostic Biomarkers Product 12.9.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Cisbio Bioassays 12.10 Signosis, Inc 12.10.1 Company profile 12.10.2 Representative Diagnostic Biomarkers Product 12.10.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Signosis, Inc 12.11 Banyan Biomarkers, Inc 12.11.1 Company profile 12.11.2 Representative Diagnostic Biomarkers Product 12.11.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Banyan Biomarkers, Inc 12.12 Biomedical Corp 12.12.1 Company profile 12.12.2 Representative Diagnostic Biomarkers Product 12.12.3 Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Biomedical Corp Chapter 13 Upstream and Downstream Market Analysis of Diagnostic Biomarkers 13.1 Industry Chain of Diagnostic Biomarkers 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Diagnostic Biomarkers 14.1 Cost Structure Analysis of Diagnostic Biomarkers 14.2 Raw Materials Cost Analysis of Diagnostic Biomarkers 14.3 Labor Cost Analysis of Diagnostic Biomarkers 14.4 Manufacturing Expenses Analysis of Diagnostic Biomarkers Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Safety Biomarkers Table Advantage and Disadvantage of Efficacy Biomarkers Table Advantage and Disadvantage of Validation Biomarkers Table Sales Volume of Diagnostic Biomarkers by Regions 2013-2017 Table Sales Value of Diagnostic Biomarkers by Regions 2013-2017 Table Production Volume of Diagnostic Biomarkers by Regions 2013-2017 Table Global Sales Volume of Diagnostic Biomarkers by Regions 2018-2023 Table Global Sales Value of Diagnostic Biomarkers by Regions 2018-2023 Table Global Production Volume of Diagnostic Biomarkers by Regions 2018-2023 Table Sales Volume of Diagnostic Biomarkers by Types 2013-2017 Table Sales Value of Diagnostic Biomarkers by Types 2013-2017 Table Sales Volume Forecast of Diagnostic Biomarkers by Types 2018-2023 Table Sales Value Forecast of Diagnostic Biomarkers by Types 2018-2023 Table Sales Volume of Diagnostic Biomarkers by Downstream Industry 2013-2017 Table Sales Volume Forecast of Diagnostic Biomarkers by Downstream Industry 2018-2023 Table North America Diagnostic Biomarkers Sales by Countries (2013-2017) Table North America Diagnostic Biomarkers Sales Share by Countries (2013-2017) Table North America Diagnostic Biomarkers Revenue by Countries (2013-2017) Table North America Diagnostic Biomarkers Revenue Market Share by Countries (2013-2017) Table North America Diagnostic Biomarkers Sales by Type (2013-2017) Table North America Diagnostic Biomarkers Sales Share by Type (2013-2017) Table North America Diagnostic Biomarkers Revenue by Type (2013-2017) Table North America Diagnostic Biomarkers Revenue Share by Type (2013-2017) Table North America Diagnostic Biomarkers Sales by Downstream Industry (2013-2017) Table North America Diagnostic Biomarkers Sales Share by Downstream Industry (2013-2017) Table Europe Diagnostic Biomarkers Sales by Countries (2013-2017) Table Europe Diagnostic Biomarkers Sales Share by Countries (2013-2017) Table Europe Diagnostic Biomarkers Revenue by Countries (2013-2017) Table Europe Diagnostic Biomarkers Revenue Market Share by Countries (2013-2017) Table Europe Diagnostic Biomarkers Sales by Type (2013-2017) Table Europe Diagnostic Biomarkers Sales Share by Type (2013-2017) Table Europe Diagnostic Biomarkers Revenue by Type (2013-2017) Table Europe Diagnostic Biomarkers Revenue Share by Type (2013-2017) Table Europe Diagnostic Biomarkers Sales by Downstream Industry (2013-2017) Table Europe Diagnostic Biomarkers Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Diagnostic Biomarkers Sales by Countries (2013-2017) Table Asia Pacific Diagnostic Biomarkers Sales Share by Countries (2013-2017) Table Asia Pacific Diagnostic Biomarkers Revenue by Countries (2013-2017) Table Asia Pacific Diagnostic Biomarkers Revenue Market Share by Countries (2013-2017) Table Asia Pacific Diagnostic Biomarkers Sales by Type (2013-2017) Table Asia Pacific Diagnostic Biomarkers Sales Share by Type (2013-2017) Table Asia Pacific Diagnostic Biomarkers Revenue by Type (2013-2017) Table Asia Pacific Diagnostic Biomarkers Revenue Share by Type (2013-2017) Table Asia Pacific Diagnostic Biomarkers Sales by Downstream Industry (2013-2017) Table Asia Pacific Diagnostic Biomarkers Sales Share by Downstream Industry (2013-2017) Table Latin America Diagnostic Biomarkers Sales by Countries (2013-2017) Table Latin America Diagnostic Biomarkers Sales Share by Countries (2013-2017) Table Latin America Diagnostic Biomarkers Revenue by Countries (2013-2017) Table Latin America Diagnostic Biomarkers Revenue Market Share by Countries (2013-2017) Table Latin America Diagnostic Biomarkers Sales by Type (2013-2017) Table Latin America Diagnostic Biomarkers Sales Share by Type (2013-2017) Table Latin America Diagnostic Biomarkers Revenue by Type (2013-2017) Table Latin America Diagnostic Biomarkers Revenue Share by Type (2013-2017) Table Latin America Diagnostic Biomarkers Sales by Downstream Industry (2013-2017) Table Latin America Diagnostic Biomarkers Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Sales by Regions (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Sales Share by Regions (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Revenue by Regions (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Sales by Type (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Sales Share by Type (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Revenue by Type (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Revenue Share by Type (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Sales by Downstream Industry (2013-2017) Table Middle East and Africa Diagnostic Biomarkers Sales Share by Downstream Industry (2013-2017) Table Production Volume of Diagnostic Biomarkers by Major Manufacturers 2013-2017 Table Production Value of Diagnostic Biomarkers by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Diagnostic Biomarkers Major Manufacturer Table Employees and Revenue Level of Diagnostic Biomarkers Major Manufacturer Table Representative Diagnostic Biomarkers Product One of Qiagen N.V. Table Representative Diagnostic Biomarkers Product Two of Qiagen N.V. Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Qiagen N.V. 2013-2017 Table Representative Diagnostic Biomarkers Product One of Perkinelmer, Inc. Table Representative Diagnostic Biomarkers Product Two of Perkinelmer, Inc. Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Perkinelmer, Inc. 2013-2017 Table Representative Diagnostic Biomarkers Product One of Merck Millipore Table Representative Diagnostic Biomarkers Product Two of Merck Millipore Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Merck Millipore 2013-2017 Table Representative Diagnostic Biomarkers Product One of Bio-Rad Laboratories, Inc. Table Representative Diagnostic Biomarkers Product Two of Bio-Rad Laboratories, Inc. Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc. 2013-2017 Table Representative Diagnostic Biomarkers Product One of Enzo Biochem, Inc. Table Representative Diagnostic Biomarkers Product Two of Enzo Biochem, Inc. Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Enzo Biochem, Inc. 2013-2017 Table Representative Diagnostic Biomarkers Product One of EKF Diagnostics Holdings, Inc. Table Representative Diagnostic Biomarkers Product Two of EKF Diagnostics Holdings, Inc. Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of EKF Diagnostics Holdings, Inc. 2013-2017 Table Representative Diagnostic Biomarkers Product One of Meso Scale Diagnostics, LLC. Table Representative Diagnostic Biomarkers Product Two of Meso Scale Diagnostics, LLC. Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Meso Scale Diagnostics, LLC. 2013-2017 Table Representative Diagnostic Biomarkers Product One of Biosims Technologies Sas Table Representative Diagnostic Biomarkers Product Two of Biosims Technologies Sas Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Biosims Technologies Sas 2013-2017 Table Representative Diagnostic Biomarkers Product One of Cisbio Bioassays Table Representative Diagnostic Biomarkers Product Two of Cisbio Bioassays Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Cisbio Bioassays 2013-2017 Table Representative Diagnostic Biomarkers Product One of Signosis, Inc Table Representative Diagnostic Biomarkers Product Two of Signosis, Inc Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Signosis, Inc 2013-2017 Table Representative Diagnostic Biomarkers Product One of Banyan Biomarkers, Inc Table Representative Diagnostic Biomarkers Product Two of Banyan Biomarkers, Inc Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Banyan Biomarkers, Inc 2013-2017 Table Representative Diagnostic Biomarkers Product One of Biomedical Corp Table Representative Diagnostic Biomarkers Product Two of Biomedical Corp Table Diagnostic Biomarkers Sales, Revenue, Price and Gross Margin of Biomedical Corp 2013-2017